Literature DB >> 13976927

Deoxyribonucleic acid synthesis in vaccinia virus-infected HeLa cells.

A J SHATKIN, N P SALZMAN.   

Abstract

Entities:  

Keywords:  DNA, VIRAL; TISSUE CULTURE; VACCINIA VIRUS

Mesh:

Substances:

Year:  1963        PMID: 13976927     DOI: 10.1016/0042-6822(63)90050-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


× No keyword cloud information.
  8 in total

1.  [THE BEHAVIOR OF VIRAL DNA IN 5-BROMODEOXYURIDINE-TREATED CELL CULTURES. I. STUDIES ON HERPESVIRUS FOR THE ANTIGEN PROPERTY AND ON THE ABSORPTION CAPACITY OF THE INFECTIOUS VIRUS].

Authors:  K E SCHNEWEIS
Journal:  Arch Gesamte Virusforsch       Date:  1965

2.  An autoradiographic and immunofluorescent study of the infectious cycle of sheeppox virus in cell cultures exposed to 5-fluorodeoxyuridine.

Authors:  J Vigário; A Terrinha; J Nunes; A Bastos; D Marques; D Correia; F Silva
Journal:  Arch Gesamte Virusforsch       Date:  1968

Review 3.  The poxviruses.

Authors:  W K Joklik
Journal:  Bacteriol Rev       Date:  1966-03

4.  Synthesis of herpes simplex virus, vaccinia virus, and adenovirus DNA in isolated HeLa cell nuclei. I. Effect of viral-specific antisera and phosphonoacetic acid.

Authors:  A Bolden; J Aucker; A Weissbach
Journal:  J Virol       Date:  1975-12       Impact factor: 5.103

5.  Vaccinia virus infection of HeLa cells. I. Synthesis of vaccinia DNA in host cell nuclei.

Authors:  P LaColla; A Weissbach
Journal:  J Virol       Date:  1975-02       Impact factor: 5.103

6.  Sequential formation of vaccinia virus proteins and viral deoxyribonucleic acid replication.

Authors:  N P Salzman; E D Sebring
Journal:  J Virol       Date:  1967-02       Impact factor: 5.103

7.  Vaccinia virus induces ribonucleotide reductase in primate cells.

Authors:  M B Slabaugh; T L Johnson; C K Mathews
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

8.  Metabolic properties of early and late vaccinia virus messenger ribonucleic acid.

Authors:  E D Sebring; N P Salzman
Journal:  J Virol       Date:  1967-06       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.